筋萎縮性側索硬化症（ALS）治療の世界市場（～2026年）

• 英文タイトル：Global Amyotrophic Lateral Sclerosis Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY10830 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は筋萎縮性側索硬化症（ALS）治療のグローバル市場について調査・分析したレポートです。種類別（薬物療法、理学療法、言語療法、その他）市場規模、用途別（病院、専門センター、研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別筋萎縮性側索硬化症（ALS）治療の競争状況、市場シェア ・世界の筋萎縮性側索硬化症（ALS）治療市場：種類別市場規模 2015年-2020年（薬物療法、理学療法、言語療法、その他） ・世界の筋萎縮性側索硬化症（ALS）治療市場：種類別市場規模予測 2021年-2026年（薬物療法、理学療法、言語療法、その他） ・世界の筋萎縮性側索硬化症（ALS）治療市場：用途別市場規模 2015年-2020年（病院、専門センター、研究センター、その他） ・世界の筋萎縮性側索硬化症（ALS）治療市場：用途別市場規模予測 2021年-2026年（病院、専門センター、研究センター、その他） ・北米の筋萎縮性側索硬化症（ALS）治療市場分析：米国、カナダ ・ヨーロッパの筋萎縮性側索硬化症（ALS）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの筋萎縮性側索硬化症（ALS）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の筋萎縮性側索硬化症（ALS）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの筋萎縮性側索硬化症（ALS）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Roche、Biogen、Mitsubishi Tanabe Pharma、GNT Pharma、Synthetic Biologics、Amkor Pharma、ViroMed、Brainstorm Therapeutics、Bausch Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Amyotrophic lateral sclerosis is a neurodegenerative disease. ALS affects the nerve cells in the brain and spinal cord that control the voluntary muscles. It is also known as the Lou Gehrig’s disease. Amyotrophic lateral sclerosis can be caused due to various factors such as genetics or environmental factors such as exposure to toxic or infectious agents, viruses, physical trauma, diet, and behavioral and occupational factors.
The North American amyotrophic lateral sclerosis market is a growing market. On a regional basis, the Americas region is segmented into North America and South America. North America is segmented into the U.S. and Canada. The increasing prevalence of ALS affected population, along with the rising older population is likely to drive the market.

Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis Treatment Market
The global Amyotrophic Lateral Sclerosis Treatment market size is projected to reach US$ 294.7 million by 2026, from US$ 274.3 million in 2020, at a CAGR of 6.9%% during 2021-2026.

Global Amyotrophic Lateral Sclerosis Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sanofi
Roche
Biogen
Mitsubishi Tanabe Pharma
GNT Pharma
Synthetic Biologics
Amkor Pharma
ViroMed
Brainstorm Therapeutics
Bausch Health

Market segment by Type, the product can be split into
Medication
Physical Therapy
Speech Therapy
Others
Market segment by Application, split into
Hospitals
Specialty Centers
Research Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medication
1.4.3 Physical Therapy
1.4.4 Speech Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Centers
1.5.4 Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Perspective (2015-2026)
2.2 Global Amyotrophic Lateral Sclerosis Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Amyotrophic Lateral Sclerosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Amyotrophic Lateral Sclerosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Market Size
3.1.1 Global Top Amyotrophic Lateral Sclerosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Amyotrophic Lateral Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio
3.2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Treatment Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis Treatment Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis Treatment Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis Treatment Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis Treatment Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis Treatment Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Introduction
13.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Introduction
13.2.4 Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.2.5 Roche Recent Development
13.3 Biogen
13.3.1 Biogen Company Details
13.3.2 Biogen Business Overview
13.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Introduction
13.3.4 Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.3.5 Biogen Recent Development
13.4 Mitsubishi Tanabe Pharma
13.4.1 Mitsubishi Tanabe Pharma Company Details
13.4.2 Mitsubishi Tanabe Pharma Business Overview
13.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
13.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.4.5 Mitsubishi Tanabe Pharma Recent Development
13.5 GNT Pharma
13.5.1 GNT Pharma Company Details
13.5.2 GNT Pharma Business Overview
13.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
13.5.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.5.5 GNT Pharma Recent Development
13.6 Synthetic Biologics
13.6.1 Synthetic Biologics Company Details
13.6.2 Synthetic Biologics Business Overview
13.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Introduction
13.6.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.6.5 Synthetic Biologics Recent Development
13.7 Amkor Pharma
13.7.1 Amkor Pharma Company Details
13.7.2 Amkor Pharma Business Overview
13.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Introduction
13.7.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.7.5 Amkor Pharma Recent Development
13.8 ViroMed
13.8.1 ViroMed Company Details
13.8.2 ViroMed Business Overview
13.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Introduction
13.8.4 ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.8.5 ViroMed Recent Development
13.9 Brainstorm Therapeutics
13.9.1 Brainstorm Therapeutics Company Details
13.9.2 Brainstorm Therapeutics Business Overview
13.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Introduction
13.9.4 Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.9.5 Brainstorm Therapeutics Recent Development
13.10 Bausch Health
13.10.1 Bausch Health Company Details
13.10.2 Bausch Health Business Overview
13.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Introduction
13.10.4 Bausch Health Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020)
13.10.5 Bausch Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Amyotrophic Lateral Sclerosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Amyotrophic Lateral Sclerosis Treatment Revenue
Table 3. Ranking of Global Top Amyotrophic Lateral Sclerosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medication
Table 6. Key Players of Physical Therapy
Table 7. Key Players of Speech Therapy
Table 8. Key Players of Others
Table 9. Global Amyotrophic Lateral Sclerosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2015-2020)
Table 13. Global Amyotrophic Lateral Sclerosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Amyotrophic Lateral Sclerosis Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Amyotrophic Lateral Sclerosis Treatment Players
Table 20. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Players (2015-2020)
Table 22. Global Top Amyotrophic Lateral Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Treatment as of 2019)
Table 23. Global Amyotrophic Lateral Sclerosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Amyotrophic Lateral Sclerosis Treatment Product Solution and Service
Table 26. Date of Enter into Amyotrophic Lateral Sclerosis Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Type (2015-2020)
Table 30. Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Application (2015-2020)
Table 32. Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Amyotrophic Lateral Sclerosis Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 36. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 38. North America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 42. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 44. Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 48. China Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 50. China Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 54. Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 56. Japan Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 60. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 66. India Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 68. India Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Amyotrophic Lateral Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Amyotrophic Lateral Sclerosis Treatment Market Share (2019-2020)
Table 72. Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Amyotrophic Lateral Sclerosis Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Amyotrophic Lateral Sclerosis Treatment Market Share by Application (2015-2020)
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Product
Table 79. Sanofi Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 80. Sanofi Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Product
Table 84. Roche Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 85. Roche Recent Development
Table 86. Biogen Company Details
Table 87. Biogen Business Overview
Table 88. Biogen Product
Table 89. Biogen Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 90. Biogen Recent Development
Table 91. Mitsubishi Tanabe Pharma Company Details
Table 92. Mitsubishi Tanabe Pharma Business Overview
Table 93. Mitsubishi Tanabe Pharma Product
Table 94. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 95. Mitsubishi Tanabe Pharma Recent Development
Table 96. GNT Pharma Company Details
Table 97. GNT Pharma Business Overview
Table 98. GNT Pharma Product
Table 99. GNT Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 100. GNT Pharma Recent Development
Table 101. Synthetic Biologics Company Details
Table 102. Synthetic Biologics Business Overview
Table 103. Synthetic Biologics Product
Table 104. Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 105. Synthetic Biologics Recent Development
Table 106. Amkor Pharma Company Details
Table 107. Amkor Pharma Business Overview
Table 108. Amkor Pharma Product
Table 109. Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 110. Amkor Pharma Recent Development
Table 111. ViroMed Business Overview
Table 112. ViroMed Product
Table 113. ViroMed Company Details
Table 114. ViroMed Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 115. ViroMed Recent Development
Table 116. Brainstorm Therapeutics Company Details
Table 117. Brainstorm Therapeutics Business Overview
Table 118. Brainstorm Therapeutics Product
Table 119. Brainstorm Therapeutics Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 120. Brainstorm Therapeutics Recent Development
Table 121. Bausch Health Company Details
Table 122. Bausch Health Business Overview
Table 123. Bausch Health Product
Table 124. Bausch Health Revenue in Amyotrophic Lateral Sclerosis Treatment Business (2015-2020) (Million US$)
Table 125. Bausch Health Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medication Features
Figure 3. Physical Therapy Features
Figure 4. Speech Therapy Features
Figure 5. Others Features
Figure 6. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Specialty Centers Case Studies
Figure 9. Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Treatment Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Amyotrophic Lateral Sclerosis Treatment Market Share by Players in 2019
Figure 17. Global Top Amyotrophic Lateral Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Treatment Revenue in 2019
Figure 19. North America Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Amyotrophic Lateral Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

---